KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Share-based Compensation (2016 - 2025)

Jazz Pharmaceuticals has reported Share-based Compensation over the past 16 years, most recently at $70.9 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $70.9 million for Q4 2025, up 0.95% from a year ago — trailing twelve months through Dec 2025 was $291.1 million (up 17.37% YoY), and the annual figure for FY2025 was $291.1 million, up 17.37%.
  • Share-based Compensation for Q4 2025 was $70.9 million at Jazz Pharmaceuticals, down from $88.1 million in the prior quarter.
  • Over the last five years, Share-based Compensation for JAZZ hit a ceiling of $88.1 million in Q3 2025 and a floor of $34.5 million in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $56.7 million (2022), compared with a mean of $58.9 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 75.38% in 2021 and later dropped 14.0% in 2023.
  • Jazz Pharmaceuticals' Share-based Compensation stood at $53.1 million in 2021, then grew by 15.89% to $61.6 million in 2022, then decreased by 14.0% to $52.9 million in 2023, then skyrocketed by 32.58% to $70.2 million in 2024, then grew by 0.95% to $70.9 million in 2025.
  • The last three reported values for Share-based Compensation were $70.9 million (Q4 2025), $88.1 million (Q3 2025), and $64.5 million (Q2 2025) per Business Quant data.